Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6-Mediated Changes in Connexin Expression
Pietro Enea Lazzerini, Franco Laghi-Pasini, Maurizio Acampa, Ujala Srivastava, Iacopo Bertolozzi, Beatrice Giabbani, Francesco Finizola, Francesca Vanni, Aleksander Dokollari, Mariarita Natale, Gabriele Cevenini, Enrico Selvi, Nicola Migliacci, Massimo Maccherini, Mohamed Boutjdir, Pier Leopoldo Capecchi, Pietro Enea Lazzerini, Franco Laghi-Pasini, Maurizio Acampa, Ujala Srivastava, Iacopo Bertolozzi, Beatrice Giabbani, Francesco Finizola, Francesca Vanni, Aleksander Dokollari, Mariarita Natale, Gabriele Cevenini, Enrico Selvi, Nicola Migliacci, Massimo Maccherini, Mohamed Boutjdir, Pier Leopoldo Capecchi
Abstract
Background Systemic inflammation is a strong predictor of atrial fibrillation. A key role for electrical remodeling is increasingly recognized, and experimental data suggest that inflammatory cytokines can directly affect connexins resulting in gap-junction dysfunction. We hypothesized that systemic inflammation, regardless of its origin, promotes atrial electric remodeling in vivo, as a result of cytokine-mediated changes in connexin expression. Methods and Results Fifty-four patients with different inflammatory diseases and elevated C-reactive protein were prospectively enrolled, and electrocardiographic P-wave dispersion indices, cytokine levels (interleukin-6, tumor necrosis factor-α, interleukin-1, interleukin-10), and connexin expression (connexin 40, connexin 43) were measured during active disease and after reducing C-reactive protein by >75%. Moreover, peripheral blood mononuclear cells and atrial tissue specimens from an additional sample of 12 patients undergoing cardiac surgery were evaluated for atrial and circulating mRNA levels of connexins. Finally, in vitro effects of interleukin-6 on connexin expression were studied in HL-1 mouse atrial myocytes. In patients with active inflammatory diseases, P-wave dispersion indices were increased but rapidly decreased within days when C-reactive protein normalizes and interleukin-6 levels decline. In inflammatory disease patients, both P-wave dispersion indices and interleukin-6 changes were inversely associated with circulating connexin levels, and a positive correlation between connexin expression in peripheral blood mononuclear cells and atrial tissue was demonstrated. Moreover, interleukin-6 significantly reduced connexin expression in HL-1 cells. Conclusions Our data suggest that regardless of specific etiology and organ localization, systemic inflammation, via interleukin-6 elevation, rapidly induces atrial electrical remodeling by down-regulating cardiac connexins. Although transient, these changes may significantly increase the risk for atrial fibrillation and related complications during active inflammatory processes.
Keywords: P‐wave indices; atrial electrical remodeling; atrial fibrillation; connexins; interleukin‐6; systemic inflammation.
Figures
References
- Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;837–847.
- Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet. 2010;1212–1223.
- Kato T, Iwasaki YK, Nattel S. Connexins and atrial fibrillation: filling in the gaps. Circulation. 2012;203–206.
- Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;230–243.
- Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res. 2008;9–19.
- Saffitz JE, Laing JG, Yamada KA. Connexin expression and turnover: implications for cardiac excitability. Circ Res. 2000;723–728.
- Boutjdir M, Le Heuzey JY, Lavergne T, Chauvaud S, Guize L, Carpentier A, Peronneau P. Inhomogeneity of cellular refractoriness in human atrium: factor of arrhythmia? Pacing Clin Electrophysiol. 1986;1095–1100.
- Delmar M, Makita N. Cardiac connexins, mutations and arrhythmias. Curr Opin Cardiol. 2012;236–241.
- Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;2263–2270.
- Lazzerini PE, Capecchi PL, Laghi‐Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J. 2017;717–1727.
- Lazzerini PE, Capecchi PL, El‐Sherif N, Laghi‐Pasini F, Boutjdir M. Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies. J Am Heart Assoc. 2018;e010595 DOI: 10.1161/JAHA.118.010595.
- Lazzerini PE, Laghi‐Pasini F, Boutjdir M, Capecchi PL. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019;63–64.
- Sawaya SE, Rajawat YS, Rami TG, Szalai G, Price RL, Sivasubramanian N, Mann DL, Khoury DS. Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac‐restricted overexpression of tumor necrosis factor. Am J Physiol Heart Circ Physiol. 2007;H1561–H1567.
- Liew R, Khairunnisa K, Gu Y, Tee N, Yin NO, Naylynn TM, Moe KT. Role of tumor necrosis factor‐α in the pathogenesis of atrial fibrosis and development of an arrhythmogenic substrate. Circ J. 2013;1171–1179.
- Sun Z, Zhou D, Xie X, Wang S, Wang Z, Zhao W, Xu H, Zheng L. Cross‐talk between macrophages and atrial myocytes in atrial fibrillation. Basic Res Cardiol. 2016;63.
- Fernandez‐Cobo M, Gingalewski C, Drujan D, De Maio A. Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine. 1999;216–224.
- Magnani JW, Williamson MA, Ellinor PT, Monahan KM, Benjamin EJ. P wave indices: current status and future directions in epidemiology, clinical, and research applications. Circ Arrhythm Electrophysiol. 2009;72–79.
- Magnani JW, Johnson VM, Sullivan LM, Lubitz SA, Schnabel RB, Ellinor PT, Benjamin EJ. P‐wave indices: derivation of reference values from the Framingham Heart Study. Ann Noninvasive Electrocardiol. 2010;344–352.
- Okutucu S, Aytemir K, Oto A. P‐wave dispersion: what we know till now? JRSM Cardiovasc Dis. 2016;2048004016639443.
- Perez MV, Dewey FE, Marcus R, Ashley EA, Al‐Ahmad AA, Wang PJ, Froelicher VF. Electrocardiographic predictors of atrial fibrillation. Am Heart J. 2009;622–628.
- Tsioufis C, Syrseloudis D, Hatziyianni A, Tzamou V, Andrikou I, Tolis P, Toutouzas K, Michaelidis A, Stefanadis C. Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects. Am J Hypertens. 2010;202–207.
- Zheng LH, Yao Y, Wu LM, Zhang KJ, Zhang S. Relationships of high‐sensitive C‐reactive protein and P‐wave dispersion in lone atrial fibrillation. Chin Med J (Engl). 2015;1450–1454.
- Yavuzkir M, Ozturk A, Dagli N, Koca S, Karaca I, Balin M, Işik A. Effect of ongoing inflammation in rheumatoid arthritis on P‐wave dispersion. J Int Med Res. 2007;796–802.
- Bacaksiz A, Erdogan E, Tasal A, Vatankulu MA, Kul S, Sevgili E, Ertas G, Dizman D, Onsun N, Uysal O. Electrocardiographic P‐wave characteristics in patients with psoriasis vulgaris. Ups J Med Sci. 2013;35–41.
- Aksoy H, Okutucu S, Sayin BY, Ercan EA, Kaya EB, Ozdemir O, Inanici F, Aytemir K, Oto A. Assessment of cardiac arrhythmias in patients with ankylosing spondylitis by signal‐averaged P wave duration and P wave dispersion. Eur Rev Med Pharmacol Sci. 2016;1123–1129.
- Dogan Y, Soylu A, Eren GA, Poturoglu S, Dolapcioglu C, Sonmez K, Duman H, Sevindir I. Evaluation of QT and P wave dispersion and mean platelet volume among inflammatory bowel disease patients. Int J Med Sci. 2011;540–546.
- Ozdemir R, Isguder R, Kucuk M, Karadeniz C, Ceylan G, Katipoglu N, Yilmazer MM, Yozgat Y, Mese T, Agin H. A valuable tool in predicting poor outcome due to sepsis in pediatric intensive care unit: Tp‐e/Qt ratio. J Trop Pediatr. 2016;377–384.
- Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta‐analysis. Int J Rheum Dis. 2017;434–441.
- Ahlehoff O, Gislason GH, Jørgensen CH, Lindhardsen J, Charlot M, Olesen JB, Abildstrøm SZ, Skov L, Torp‐Pedersen C, Hansen PR. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish nationwide cohort study. Eur Heart J. 2012;2054–2064.
- Kristensen SL, Lindhardsen J, Ahlehoff O, Erichsen R, Lamberts M, Khalid U, Torp‐Pedersen C, Nielsen OH, Gislason GH, Hansen PR. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study. Europace. 2014;477–484.
- Shahreyar M, Fahhoum R, Akinseye O, Bhandari S, Dang G, Khouzam RN. Severe sepsis and cardiac arrhythmias. Ann Transl Med. 2018;6.
- Bacani AK, Crowson CS, Roger VL, Gabriel SE, Matteson EL. Increased incidence of atrial fibrillation in patients with rheumatoid arthritis. Biomed Res Int. 2015;809514.
- Dilaveris PE, Gialafos JE. P‐wave duration and dispersion analysis: methodological considerations. Circulation. 2001;e111.
- Acampa M, Lazzerini PE, Guideri F, Rechichi S, Capecchi PL, Maccherini M, Laghi‐Pasini F. Homocysteine and P wave dispersion in patients with heart transplantation. Clin Transplant. 2011;119–125.
- Gao G, Brahmanandam V, Raicu M, Gu L, Zhou L, Kasturirangan S, Shah A, Negi SI, Wood MR, Desai AA, Tatooles A, Schwartz A, Dudley SC. Enhanced risk profiling of implanted defibrillator shocks with circulating SCN5a mRNA splicing variants: a pilot trial. J Am Coll Cardiol. 2014;2261–2269.
- Jiang N, Zhou A, Prasad B, Zhou L, Doumit J, Shi G, Imran H, Kaseer B, Millman R, Dudley SC. Obstructive sleep apnea and circulating potassium channel levels. J Am Heart Assoc. 2016;e003666 DOI: 10.1161/JAHA.116.003666.
- Wong CW, Christen T, Kwak BR. Connexins in leukocytes: shuttling messages? Cardiovasc Res. 2004;357–367.
- Mendoza‐Naranjo A, Bouma G, Pereda C, Ramírez M, Webb KF, Tittarelli A, López MN, Kalergis AM, Thrasher AJ, Becker DL, Salazar‐Onfray F. Functional gap junctions accumulate at the immunological synapse and contribute to T cell activation. J Immunol. 2011;3121–3132.
- Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ. HL‐1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A. 1998;2979–2984.
- Geng HH, Li R, Su YM, Pan HY, Pan M, Ji XP. A functional single‐nucleotide polymorphism in interleukin‐6 promoter is associated with P wave dispersion in hypertensive subjects with atrial fibrillation. Int J Clin Exp Med. 2014;4434–4440.
- Baillet A, Gossec L, Paternotte S, Etcheto A, Combe B, Meyer O, Mariette X, Gottenberg JE, Dougados M. Evaluation of serum interleukin‐6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort. Arthritis Care Res (Hoboken). 2015;905–912.
- Takeuchi T, Miyasaka N, Tatsuki Y, Yano T, Yoshinari T, Abe T, Koike T. Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;1208–1215.
- Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets—an updated view. Mediators Inflamm. 2013;165974.
- Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin‐1 serum levels during severe sepsis in humans. Crit Care Med. 1989;975–978.
- Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple‐system organ failure and mortality. Chest. 1993;565–575.
- Whang KT, Vath SD, Becker KL, Snider RH, Nylen ES, Muller B, Li Q, Tamarkin L, White JC. Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock. 2000;73–78.
- Roth J, Conn CA, Kluger MJ, Zeisberger E. Kinetics of systemic and intrahypothalamic IL‐6 and tumor necrosis factor during endotoxin fever in guinea pigs. Am J Physiol. 1993;R653–R658.
- Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin‐6 (IL‐6), IL‐1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL‐6 suppresses IL‐1 and TNF. Blood. 1990;40–47.
- Baum JR, Long B, Cabo C, Duffy HS. Myofibroblasts cause heterogeneous Cx43 reduction and are unlikely to be coupled to myocytes in the healing canine infarct. Am J Physiol Heart Circ Physiol. 2012;H790–H800.
- Meierhenrich R, Steinhilber E, Eggermann C, Weiss M, Voglic S, Bögelein D, Gauss A, Georgieff M, Stahl W. Incidence and prognostic impact of new‐onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care. 2010;R108.
- Mc Cormack O, Zaborowski A, King S, Healy L, Daly C, OʼFarrell N, Donohoe CL, Ravi N, Reynolds JV. New‐onset atrial fibrillation post‐surgery for esophageal and junctional cancer: incidence, management, and impact on short‐ and long‐term outcomes. Ann Surg. 2014;772–778; discussion 778.
- Anatoĺevna RO, Veniaminovich FO, Mikhaylovich KS. Predictors of new‐onset atrial fibrillation in elderly patients with coronary artery disease after coronary artery bypass graft. J Geriatr Cardiol. 2016;444–449.
- Lazzerini PE, Acampa M, Capecchi PL, Fineschi I, Selvi E, Moscadelli V, Zimbone S, Gentile D, Galeazzi M, Laghi‐Pasini F. Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation. Arthritis Care Res (Hoboken). 2015;332–339.
Source: PubMed